Spots Global Cancer Trial Database for ovarian diseases
Every month we try and update this database with for ovarian diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | NCT00210249 | Lymphoma Digestive Syste... Ovarian Disease... Pulmonary Disea... Prostatic Disea... Bladder Disease | 70 Years - | Institut Bergonié | ||
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery | NCT02847832 | Patients With A... | Standardized tr... | - | KU Leuven | |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer | NCT00816764 | Carcinoma Ovarian Cancer Ovarian Disease... Ovarian Neoplas... | AGS-8M4 | 18 Years - | Astellas Pharma Inc | |
| Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer | NCT01610869 | Ovarian Cancer Fallopian Tube ... | BIBF 1120 | 18 Years - | University College, London | |
| A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) | NCT00749502 | Solid Tumors Chronic Lymphoc... T-cell-prolymph... | MK-4827 | 18 Years - | Tesaro, Inc. | |
| NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer | NCT03146663 | Ovarian Cancer | NUC-1031 500 mg NUC-1031 750mg | 18 Years - | NuCana plc | |
| Mediterranean Diet as Treatment for Normal Weight Women With PCOS | NCT02396264 | Polycystic Ovar... | mediterranean d... normocaloric di... | 18 Years - 35 Years | Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer | NCT01610869 | Ovarian Cancer Fallopian Tube ... | BIBF 1120 | 18 Years - | University College, London | |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer | NCT04519151 | Ovarian Neoplas... Carcinoma, Ovar... Neoplasm of Sto... Ovarian Disease... Genital Neoplas... Ovarian Epithel... Urogenital Neop... Neoplasms, Glan... | Pembrolizumab Lenvatinib | 18 Years - | Sheba Medical Center | |
| Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer | NCT01462890 | Genital Disease... Ovarian Disease... Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... | Bevacizumab Paclitaxel Carboplatin specialized pat... | 18 Years - | AGO Study Group | |
| Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. | NCT05753826 | Ovarian Neoplas... Ovarian Disease... | Adebrelimab Fuzuloparib | 18 Years - 70 Years | Fujian Cancer Hospital | |
| A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer | NCT01016054 | Carcinoma Ovarian Cancer Ovarian Disease... Ovarian Neoplas... | AGS-8M4 Pegylated lipos... gemcitabine carboplatin | 18 Years - | Astellas Pharma Inc | |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | NCT00210249 | Lymphoma Digestive Syste... Ovarian Disease... Pulmonary Disea... Prostatic Disea... Bladder Disease | 70 Years - | Institut Bergonié | ||
| Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma | NCT01460979 | Genital Disease... Ovarian Disease... Ovarian Neoplas... Endometrial Neo... | Temsirolimus | 18 Years - | AGO Study Group | |
| Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer | NCT01610869 | Ovarian Cancer Fallopian Tube ... | BIBF 1120 | 18 Years - | University College, London | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Mediterranean Diet Versus Hypocaloric Diet in PCOS | NCT02397174 | Polycystic Ovar... | mediterranean d... hypocaloric die... | 18 Years - 35 Years | Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
